AIFF (Firefly Neuroscience) 3-Year EBITDA Growth Rate: -36.60% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AIFF Firefly Neuroscience Inc AIFF
12 GF Score
Price $1.10
! 3 Warning Signs
View Full Analysis

What is Firefly Neuroscience 3-Year EBITDA Growth Rate?

Firefly Neuroscience AIFF +1.85% 12 3-Year EBITDA Growth Rate is -36.60% as of Jun. 2026. GuruFocus rates AIFF with a GF Score™ of 12/100. The stock has 3 warning signs investors should review. Among 2,059 Software companies, Firefly Neuroscience ranks worse than 92.76% on this metric.

Firefly Neuroscience's EBITDA per Share for the three months ended in Jun. 2026 was $-0.09.

During the past 3 years, the average EBITDA Per Share Growth Rate was -36.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 5 years, the highest 3-Year average EBITDA Per Share Growth Rate of Firefly Neuroscience was -29.00% per year. The lowest was -36.60% per year. And the median was -32.80% per year.


Firefly Neuroscience  (NAS:AIFF) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Firefly Neuroscience 3-Year EBITDA Growth Rate Related Terms


AIFF vs RCT, SMSI, FTFT: 3-Year EBITDA Growth Rate Comparison

For the Software - Application subindustry, Firefly Neuroscience's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Firefly Neuroscience 3-Year EBITDA Growth Rate vs Software Industry

For the Software industry and Technology sector, Firefly Neuroscience's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Firefly Neuroscience's 3-Year EBITDA Growth Rate falls into.


AIFF
12GF Score
Firefly Neuroscience Inc AIFF
3-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Firefly Neuroscience 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 3-Year EBITDA Growth Rate of -36.60% mean?
Firefly Neuroscience (AIFF) has a 3-Year EBITDA Growth Rate of -36.60% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Firefly Neuroscience and its competitors. According to the industry distribution chart, Firefly Neuroscience ranks #1910 out of 2059 companies in the Software industry, placing it in the top 92.8%.
Is Firefly Neuroscience's 3-Year EBITDA Growth Rate too high?
Firefly Neuroscience's current 3-Year EBITDA Growth Rate is -36.60%. Based on the distribution chart, Firefly Neuroscience ranks #1910 out of 2059 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, Firefly Neuroscience has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Firefly Neuroscience's 3-Year EBITDA Growth Rate compare to RCT and SMSI?
According to the Software industry distribution chart, Firefly Neuroscience ranks #1910 out of 2059 companies for 3-Year EBITDA Growth Rate. This places Firefly Neuroscience in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 12.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Software company?
The median 3-Year EBITDA Growth Rate among Software companies is 12.10, based on 2,059 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Firefly Neuroscience and its competitors. For the Software industry, the median 3-Year EBITDA Growth Rate is 12.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Firefly Neuroscience's current 3-Year EBITDA Growth Rate is -36.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Firefly Neuroscience stock overvalued right now?
Firefly Neuroscience (AIFF) has a current 3-Year EBITDA Growth Rate of -36.60%. The current 3-Year EBITDA Growth Rate is -36.60%. Firefly Neuroscience's overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Firefly Neuroscience (AIFF), the current 3-Year EBITDA Growth Rate is -36.60% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Firefly Neuroscience Business Description

Address 1100 Military Road, Kenmore, NY, USA, 14217
Firefly Neuroscience Inc is an artificial intelligence company advancing precision neuroscience, applying AI and large-scale electrophysiological data to give clinicians a more complete, objective picture of how an individual patient's brain is functioning. The firm is developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The company has one reportable segment: the BNA platform. The Company derives revenue from North America.
12GF Score

Get the complete analysis for AIFF

3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.10
Price